Pascale Fisel
Tuebingen, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Characterization of the breast cancer resistance protein (BCRP/ABCG2) in clear cell renal cell carcinoma.
Journal: International journal of cancer
Published: February 15, 2018
Selective Inhibition of the Lactate Transporter MCT4 Reduces Growth of Invasive Bladder Cancer.
Journal: Molecular cancer therapeutics
Published: February 07, 2018
Clinical and Functional Relevance of the Monocarboxylate Transporter Family in Disease Pathophysiology and Drug Therapy.
Journal: Clinical and translational science
Published: December 18, 2017
Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin.
Journal: European urology focus
Published: November 14, 2017
The importance of drug transporter characterization to precision medicine.
Journal: Expert opinion on drug metabolism & toxicology
Published: February 01, 2017
Comment on "Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin".
Journal: Science translational medicine
Published: October 20, 2016
DNA Methylation of ADME Genes.
Journal: Clinical pharmacology and therapeutics
Published: December 04, 2015
Solute carrier transporter and drug-related nephrotoxicity: the impact of proximal tubule cell models for preclinical research.
Journal: Expert opinion on drug metabolism & toxicology
Published: January 09, 2014
DNA methylation of the SLC16A3 promoter regulates expression of the human lactate transporter MCT4 in renal cancer with consequences for clinical outcome.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 25, 2013
Last Updated: 09/26/2026